Prestige Consumer Healthcare (PBH) FY2014 results: revenue $597 million, down 3.7% on the year
Prestige Consumer Healthcare Inc. (PBH) reported revenue of $597 million for fiscal 2014, the year ended 31 March 2014, down 3.7% on the year before. Net income was $73 million, up 10.9%, and diluted earnings per share $1.39. The figures are the company's own, from the 10-K it filed with the SEC on 19 May 2014.
Revenue
$597 million
-3.7% on the year
FY2010FY2014
Operating margin
31.6%
30.9% a year earlier
FY2010FY2014
Net income
$73 million
+10.9% on the year
FY2010FY2014
Diluted EPS
$1.39
+9.4% on the year
FY2010FY2014
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Revenue
597
620
441
-3.7%
Gross profit
336
344
227
-2.4%
Gross margin
56.2%
55.4%
51.6%
Operating income
189
192
103
-1.7%
Operating margin
31.6%
30.9%
23.3%
Interest expense
68.6
84.4
41.3
-18.7%
Pre-tax income
102
106
61.2
-4.0%
Income tax
29.1
40.5
23.9
-28.1%
Effective tax rate
28.6%
38.2%
39.2%
Net income
72.6
65.5
37.2
+10.9%
Net margin
12.2%
10.6%
8.4%
Diluted EPS
$1.39
$1.27
$0.73
+9.4%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Operating cash flow
112
138
67.5
-18.9%
Capital expenditure
2.8
10.3
0.6
-73.1%
Free cash flow
109
127
66.8
-14.5%
Free cash flow margin
18.2%
20.5%
15.2%
Cash from investing
-58.0
11.2
-662
Cash from financing
-41.2
-152
600
Depreciation and amortisation
13.5
13.2
10.7
+1.9%
Share-based compensation
5.1
3.8
3.1
+36.4%
Dividends paid
0.0
0.0
n/a
Diluted shares, weighted
52m
51m
51m
+1.8%
Balance sheet
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Shareholders' equity
563
478
403
+17.9%
Debt
934
971
1,124
-3.8%
Other liabilities
298
291
232
+2.4%
Total liabilities and equity
1,796
1,740
1,758
+3.2%
Fixed assets
9.6
9.9
1.3
-3.0%
Goodwill
191
168
174
+13.9%
Intangible assets
1,395
1,373
1,401
+1.6%
Cash and equivalents
28.3
15.7
19.0
+80.8%
Receivables
65.0
73.1
60.2
-11.0%
Inventory
65.6
60.2
51.1
+8.9%
Other assets
41.4
40.2
52.4
+2.9%
Total assets
1,796
1,740
1,758
+3.2%
10-K for the year ended 31 March 2014, filed 19 May 2014: the filing.